Welcome to our dedicated page for Ayr Wellness news (Ticker: AYRWF), a resource for investors and traders seeking the latest updates and insights on Ayr Wellness stock.
AYR Wellness Inc. (AYRWF) generates frequent news due to its role as a vertically integrated U.S. multi-state cannabis operator and its ongoing capital structure restructuring. Company news releases highlight both operational milestones in the cannabis business and significant developments in its financial and legal processes.
On the operational side, AYR has issued news about the opening of its first indoor cultivation facility in Florida and the launch of Kynd brand flower from that site. These updates describe expanded cultivation capacity, a curated library of cannabis genetics, and the availability of new cultivars for registered medical marijuana patients at AYR Wellness dispensaries across Florida.
A substantial portion of AYR’s recent news flow focuses on its restructuring activities. The company has announced a Restructuring Support Agreement with an ad hoc committee of consenting senior noteholders, the commencement of Article 9 foreclosure sale proceedings for certain collateral assets and equity interests of specified subsidiaries, and the result of a public auction in which senior noteholders submitted the successful credit bid. AYR has also reported the execution of a Master Purchase Agreement to transfer core assets to a newly formed acquisition vehicle owned by certain senior noteholders, subject to regulatory approvals.
Additional news items cover the execution of a senior secured Bridge Credit Agreement, extensions of a Limited Waiver Agreement with senior noteholders, and the initiation of proceedings under the Companies’ Creditors Arrangement Act in British Columbia to facilitate a court-supervised wind-down of the existing corporate parent. Leadership updates, including changes in interim executive roles, are also disclosed through news releases.
Investors and observers can use this news page to follow AYR’s operational announcements in its cannabis markets alongside detailed updates on the restructuring process, Article 9 sale, bridge financing, waiver agreements, and CCAA proceedings.
AYR Wellness (OTCQX: AYRWF) announced that interim Chief Financial Officer Donna Granato will depart effective December 31, 2025. The company said the departure occurs as AYR continues an orderly wind down of its existing corporate entity while transitioning go‑forward assets to a new AYR.
Company leaders credited Granato with leadership during the initial phases of the business's debt restructuring and ownership transition, and thanked her for contributions during a period described as complex and uncertain.
AYR Wellness (OTCQX: AYRWF) announced it has initiated CCAA proceedings in British Columbia as part of a court‑supervised restructuring under a Restructuring Support Agreement dated July 30, 2025. Core subsidiary assets will be transferred to a newly formed acquisition vehicle (NewCo) owned by certain senior noteholders, subject to regulatory approvals and closing conditions.
The company will seek a licensed insolvency trustee as monitor, the corporate parent will be wound down, Blake Holzgrafe is named Interim CEO of the corporate parent, and Davido is expected to become Interim CEO of NewCo.
AYR Wellness (OTCQX: AYRWF) announced that a public Article 9 foreclosure auction held on November 10, 2025 resulted in a successful credit bid by the company’s senior noteholders to acquire core collateral assets and subsidiary equity in FL, NJ, NV, OH, MA, PA, and VA.
The company expects to sign a Master Purchase Agreement (MPA), seek regulatory approvals to transfer licenses to a newly formed acquisition vehicle (NewCo), and commence CCAA proceedings in British Columbia to wind down the existing corporate parent.
AYR Wellness (OTCQX: AYRWF) opened its first indoor cultivation facility in Ocala, Florida on Oct. 14, 2025, a 97,580 sq. ft. site with nearly 50,000 sq. ft. of grow canopy. The facility debuts Kynd brand indoor flower including Purple Alien, Powdered Doughnuts, and Tiger Bomb and will supply AYR dispensaries statewide for registered medical patients.
AYR expects the site to employ approximately 100 team members across cultivation, operations, and technical roles and says the facility uses advanced LED lighting, sustainable irrigation, and aims for consistent harvests while conserving water.
AYR Wellness (OTCQX: AYRWF) announced commencement of Article 9 restructuring proceedings under its Restructuring Support Agreement dated July 30, 2025.
The company said Odyssey Trust, as collateral trustee, has notified disposition of collateral and launched a public foreclosure sale of certain subsidiaries’ assets across Florida, New Jersey, Nevada, Ohio, Massachusetts, and Pennsylvania. A public auction is scheduled for November 10, 2025 at 10:00 a.m. ET at Paul Hastings in New York and/or virtually. AYR said it will continue operating the businesses during the process and is cooperating with senior noteholders; qualified bidders must follow bid procedures.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has announced the filing of its unaudited interim financial statements and Management's Discussion and Analysis (MD&A) for Q1 2025. The documents are now available on SEDAR+ and SEC's EDGAR system.
The company provided definitions of non-GAAP measures used in their reporting, including "Adjusted EBITDA" and "Adjusted Gross Profit". These metrics are used to evaluate business performance and capital structure, offering investors additional perspectives on operational decision-making.
AYR Wellness (OTCQX: AYRWF) has executed a definitive senior secured bridge term loan agreement providing up to $50 million in committed funding. The Bridge Facility, secured through CSAC Holdings Inc., will support ongoing operations and facilitate business transition under the July 30, 2025 restructuring support agreement (RSA).
The facility includes multiple draws with 14% per annum interest rate payable in kind, featuring Initial Term Loans (Tranche A and B) and Delayed Draw Term Loans. Key premiums include 10% commitment premium, 10% exit premium, and 15% backstop premium. The facility requires maintaining minimum liquidity of $17.5 million and will automatically convert into a senior secured "take-back" term facility upon completion of the planned Article 9 sale transaction.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has entered into a Restructuring Support Agreement (RSA) with senior noteholders to restructure its debt and transition ownership. The agreement includes:
The deal features a $50 million Bridge Facility at 14% interest rate, an Article 9 sale process for assets in six states (Florida, Ohio, Nevada, New Jersey, Pennsylvania, and Virginia), and conversion of senior notes into 100% equity in the new company (NewCo). The restructuring involves asset sales, debt restructuring, and potential liquidation of remaining assets through Companies' Creditors Arrangement Act proceedings.
Senior noteholders will receive pro-rata shares of NewCo equity in exchange for canceling credit bid portion of notes, while remaining note balances will be entitled to proceeds from remaining asset liquidation.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has secured an additional extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 29, 2025.
The waiver covers defaults related to delayed Q1 2025 financial statements and certain payment defaults under other outstanding debt. While temporary, this agreement prevents noteholders from exercising default-related rights during the waiver period. The company continues normal operations while evaluating growth opportunities in key markets.
AYR Wellness (OTCQX: AYRWF) has secured an additional extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 25, 2025. The extension maintains the temporary waiver of certain defaults related to delayed Q1 2025 financial filings and potential payment defaults on other outstanding debt.
This agreement prevents senior noteholders from exercising default-related rights while providing AYR additional time to negotiate with senior lenders and explore strategic options to strengthen its capital structure. The company continues to operate normally while evaluating growth opportunities in key markets.
FAQ
What is the current stock price of Ayr Wellness (AYRWF)?
What is the market cap of Ayr Wellness (AYRWF)?
